---
title: DiffMC-Gen, KinGen
published: 2025-04-07
description: åˆ†å­ç”Ÿæˆï¼Œå§šå°å†›è€å¸ˆ
tags: [æ·±åº¦å­¦ä¹ , åˆ†å­ç”Ÿæˆ]
category: Papers
draft: false
---

# DiffMC-Gen

## å¼•è¨€

é•¿æœŸä»¥æ¥ï¼Œç²¾ç¡®æœ‰æ•ˆåœ°è®¾è®¡å…·æœ‰ä¸åŒç‰©ç†åŒ–å­¦æ€§è´¨çš„æ½œåœ¨è¯ç‰©åˆ†å­ä¸€ç›´æ˜¯ä¸€ä¸ªå…³é”®æŒ‘æˆ˜ã€‚è¿‘å¹´æ¥ï¼Œå„ç§åŸºäºŽæ·±åº¦å­¦ä¹ çš„ä»Žå¤´åˆ†å­ç”Ÿæˆç®—æ³•çš„å‡ºçŽ°ä¸ºè¿™ä¸€é—®é¢˜æä¾›äº†æ–°çš„æ–¹å‘ï¼Œå…¶ä¸­åŽ»å™ªæ‰©æ•£æ¨¡åž‹æ˜¾ç¤ºå‡ºå·¨å¤§çš„æ½œåŠ›ã€‚ç„¶è€Œï¼Œä»¥å‰çš„æ–¹æ³•å¾€å¾€æ— æ³•åŒæ—¶ä¼˜åŒ–å€™é€‰åŒ–åˆç‰©çš„å¤šç§æ€§è´¨ï¼Œè¿™å¯èƒ½æ˜¯ç”±äºŽç›´æŽ¥ä½¿ç”¨éžå‡ ä½•å›¾ç¥žç»ç½‘ç»œï¼ˆGNNï¼‰ï¼Œä½¿å…¶æ— æ³•å‡†ç¡®æ•èŽ·åˆ†å­æ‹“æ‰‘å’Œå‡ ä½•ä¿¡æ¯ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œå¼€å‘äº†ä¸€ç§ç”¨äºŽå¤šæ¡ä»¶åˆ†å­ç”Ÿæˆçš„åŒåŽ»å™ªæ‰©æ•£æ¨¡åž‹ï¼ˆDiffMC-Genï¼‰ï¼Œè¯¥æ¨¡åž‹é›†æˆäº†ç¦»æ•£å’Œè¿žç»­ç‰¹å¾ï¼Œä»¥æé«˜å…¶æ„ŸçŸ¥3Dåˆ†å­ç»“æž„çš„èƒ½åŠ›ã€‚æ­¤å¤–ï¼Œå®ƒè¿˜æ¶‰åŠä¸€ç§å¤šç›®æ ‡ä¼˜åŒ–ç­–ç•¥ï¼Œä»¥åŒæ—¶ä¼˜åŒ–é¶åˆ†å­çš„å¤šç§ç‰¹æ€§ï¼ŒåŒ…æ‹¬ç»“åˆäº²å’ŒåŠ›ã€è¯ç‰©ç›¸ä¼¼æ€§ã€å¯åˆæˆæ€§å’Œæ¯’æ€§ã€‚ä»Ž2Då’Œ3Dåˆ†å­ç”Ÿæˆçš„è§’åº¦æ¥çœ‹ï¼ŒDiffMC-Genç”Ÿæˆçš„åˆ†å­åœ¨æ–°é¢–æ€§å’Œç‹¬ç‰¹æ€§æ–¹é¢è¡¨çŽ°å‡ºæœ€å…ˆè¿›çš„ï¼ˆSOTAï¼‰æ€§èƒ½ï¼ŒåŒæ—¶åœ¨è¯ç‰©ç›¸ä¼¼æ€§å’Œåˆæˆæ€§æ–¹é¢å–å¾—äº†ä¸Žä»¥å‰æ–¹æ³•ç›¸å½“çš„ç»“æžœã€‚æ­¤å¤–ï¼Œç”Ÿæˆçš„åˆ†å­å¯¹ä¸‰ç§é¶è›‹ç™½â€”â€”LRRK2ã€HPK1å’ŒGLP-1å—ä½“â€”â€”å…·æœ‰è‰¯å¥½çš„ç”Ÿç‰©æ´»æ€§å’Œè¯ç‰©æ ·ç‰¹æ€§ï¼ŒåŒæ—¶ä¿æŒäº†é«˜æ ‡å‡†çš„æœ‰æ•ˆæ€§ã€å”¯ä¸€æ€§å’Œæ–°é¢–æ€§ã€‚è¿™äº›ç»“æžœå¼ºè°ƒäº†å…¶åœ¨è¯ç‰©è®¾è®¡ä¸­çš„å®žé™…åº”ç”¨æ½œåŠ›ã€‚

## æ•°æ®

- `QM9` : 134k å°åˆ†å­ï¼ŒåŒ…å« C,H,O,N,F äº”ç±»å…ƒç´ ï¼Œæœ‰é‡åŒ–æ€§è´¨çš„ä¸€ä¸ªå°åˆ†å­åº“
- `CSD` : CSD åŸºæœ¬ä¸ŠåŒ…æ‹¬æ‰€æœ‰å·²å‘è¡¨çš„å…·æœ‰æ™¶ä½“ç»“æž„çš„æœ‰æœºå’Œé‡‘å±žæœ‰æœºåŒ–åˆç‰©ã€‚60K æœ‰ 3D æž„è±¡çš„åˆ†å­ã€‚
- `MOSES` : åŒ…å«ç”± ZINC æ¸…æ´—å¾—åˆ°çš„ 1.9m å…ˆå¯¼åŒ–åˆç‰©åˆ†å­ã€‚æ¯ä¸ªåˆ†å­å¹³å‡å«æœ‰ 29 ä¸ªåŽŸå­ã€‚ä½¿ç”¨ RDKit ç”Ÿæˆ 3D æž„è±¡ç”¨ UFF ç«‹åœºä¼˜åŒ–

## æž¶æž„

![Figure 1](DiffMC-Gen_1.png)

### æ‰©æ•£æ¨¡åž‹

- (a): è¾“å…¥åŒ…æ‹¬ï¼ŒèŠ‚ç‚¹ X è¡¨ç¤ºä¸º one-hot å‘é‡ï¼Œè¾¹ E è¡¨ç¤ºä¸º one-hot å‘é‡ï¼Œå…¨å±€ç‰¹å¾ y åˆ†ä¸ºå››ä¸ªåˆ†åˆ«æ˜¯ **Pharmacophore matching score**ï¼Œ**Acute Oral Toxicity**ï¼Œ**QED**ï¼Œ**SA**ï¼Œä»¥åŠæ¯ä¸ªåŽŸå­ 3D åæ ‡ä¿¡æ¯
- (b): åŠ å™ªè¿‡ç¨‹ï¼šèŠ‚ç‚¹å’Œè¾¹çš„è¾“å…¥è¿›è¡Œ cat ç„¶åŽæ·»åŠ å™ªå£°ï¼Œä½ç½®ä¿¡æ¯å•ç‹¬æ·»åŠ å™ªå£°ï¼Œä¹‹åŽèšåˆæ±‚å†æ·»åŠ  y ä¿¡æ¯å¾—åˆ°ï¼ˆXï¼ŒEï¼ŒPosï¼Œyï¼‰
- (c): åŽ»å™ªè¿‡ç¨‹ï¼š  
    - `Discrete denoising process`: ï¼ˆXï¼ŒEï¼Œyï¼‰--> å›¾ transformer Feature wise NLP -->  Dynamically Composable Multi-Head Attention (DCMHA) --> ï¼ˆX'ï¼ŒE'ï¼Œy'ï¼‰
    - `Continuous denoising process`: ï¼ˆXï¼ŒPosï¼Œyï¼‰--> SE(3)-equivariant local isomorphism --> ï¼ˆX'ï¼ŒPos'ï¼‰
- (d): é‡‡æ ·

### çº¦æŸæ€§è´¨

- `Pharmacophore matching score`: 0(unfavorable)-1(favorable) 
- `Acute Oral Toxicity`: 0(favorable)-1(unfavorable) 
- `QED`: 0(undrug-like)-1(drug-like) 
- `SA`: 0(favorable)-1(unfavorable) 

### ç»“åˆæ‰©æ•£æ¨¡åž‹ä¸Žçº¦æŸæ€§è´¨

- æ¡ä»¶æ‰©æ•£æ¨¡åž‹ä¸­ï¼Œç¦»æ•£æ¨¡åž‹æ˜Žç¡®åœ°åµŒå…¥äº†æ¡ä»¶åˆ†å¸ƒï¼Œè¯¥åˆ†å¸ƒåœ¨ä¼ä¸šä¸­å…·æœ‰å››ç§ä¸åŒçš„çº¦æŸï¼ŒåŒæ—¶é‡‡ç”¨äº†ä¸€ç§ç”¨äºŽéšå¼æŽ§åˆ¶çš„æ³¨æ„æœºåˆ¶ã€‚åŒæ—¶ï¼Œè¿žç»­æ¨¡åž‹ä»…è€ƒè™‘è¯æ•ˆå›¢åŒ¹é…ç³»æ•°ã€‚
- éžæ¡ä»¶æ‰©æ•£æ¨¡åž‹è®­ç»ƒä¾§é‡äºŽä¸åŒ…å«å…¨å±€ç‰¹å¾çš„ç¦»æ•£æ¨¡åž‹ã€‚åœ¨é‡‡æ ·ä¸­é‡‡ç”¨å›žå½’å™¨å¼•å¯¼çš„æ‰©æ•£æ–¹æ³•ï¼Œå…¶ä¸­ $$Ï•_ðœƒ$$ åœ¨æ¯ä¸ªé‡‡æ ·æ­¥éª¤è°ƒèŠ‚é¢„æµ‹çš„åˆ†å¸ƒï¼Œå°†å…¶å¼•å¯¼åˆ°å…·æœ‰æ‰€éœ€ç‰¹æ€§çš„åˆ†å­å›¾ã€‚

## è¯„ä»·æŒ‡æ ‡

- `Glide score` : ä¼°è®¡é…ä½“å’Œé¶æ ‡ä¹‹é—´çš„ç»“åˆäº²å’ŒåŠ›
- `Success rate` : QED â‰¥ 0.6 ä¸” SA è¯„åˆ† â‰¤0.4
- `Novelty` : ä»£è¡¨äº†æ¨¡åž‹ç”Ÿæˆä¸Žè®­ç»ƒé›†ä¸­çš„åˆ†å­æˆ–çŽ°æœ‰å·²çŸ¥åˆ†å­ç»“æž„ä¸åŒçš„åˆ†å­çš„èƒ½åŠ›
- `Uniqueness` : ç”Ÿæˆçš„åˆ†å­çš„åŒ–å­¦å›¾åœ¨ç”Ÿæˆçš„æ ·å“ä¸­æ˜¯å¦å”¯ä¸€
- `Validity` : éµå®ˆå¸¸è§åŒ–å­¦è§„åˆ™ï¼ˆå¦‚åŒ–åˆä»·ï¼‰çš„ç”Ÿæˆåˆ†å­
- `Diversity` : 1.å†…éƒ¨å¤šæ ·æ€§ï¼ˆIntDivï¼‰ï¼Œé€šè¿‡æ­ç¤ºç”Ÿæˆåˆ†å­ä¹‹é—´çš„ç»“æž„å·®å¼‚æ¥è¯„ä¼°ç”Ÿæˆé›†åˆå†…çš„å¤šæ ·æ€§ï¼Œ2.FrÃ©chet ChemNetè·ç¦»ï¼ˆFCDï¼‰ï¼Œè¡¡é‡ç”Ÿæˆåˆ†å­å’ŒçœŸå®žåˆ†å­åˆ†å¸ƒä¹‹é—´çš„ç›¸ä¼¼æ€§ï¼ŒåŒ…æ‹¬ç»“æž„å’ŒåŒ–å­¦ç›¸ä¼¼æ€§ã€‚
- `energy ratio` : è¯„ä¼°ç”Ÿæˆåˆ†å­çš„å¯é æ€§

## ç»“æžœ

![Figure 2](DiffMC-Gen_2.png)


![Figure 3](DiffMC-Gen_3.png)


![Figure 4](DiffMC-Gen_4.png)


![Figure 5](DiffMC-Gen_5.png)


![Figure 6](DiffMC-Gen_6.png)


![Figure 7](DiffMC-Gen_7.png)


![Figure 8](DiffMC-Gen_8.png)


![Figure 9](DiffMC-Gen_9.png)


## ç»“è®º

åœ¨è¿™ç¯‡è®ºæ–‡ä¸­ï¼Œæˆ‘ä»¬å¼€å‘äº†ä¸€ç§æ–°çš„åˆ†å­ç”Ÿæˆæ¨¡åž‹DiffMC-Genï¼Œç”¨äºŽå¤šæ¡ä»¶åˆ†å­ç”Ÿæˆï¼Œé€šè¿‡æ•´åˆç¦»æ•£å’Œè¿žç»­æ‰©æ•£æ¨¡åž‹æ¥å¢žå¼ºå…¶æ„ŸçŸ¥3Dåˆ†å­ç»“æž„çš„èƒ½åŠ›ã€‚åœ¨ç¦»æ•£å›¾æ‰©æ•£ç½‘ç»œä¸­ï¼Œé‡‡ç”¨äº†ä¸€ç§åŠ¨æ€å¯ç»„åˆçš„å¤šå¤´æ³¨æ„åŠ›æœºåˆ¶ï¼Œå°†æ³¨æ„åŠ›å¾—åˆ†å’Œæ¡ä»¶æƒé‡çŸ©é˜µç›¸ç»“åˆï¼Œä»¥é™ä½Žè®¡ç®—æˆæœ¬ï¼ŒåŒæ—¶å¢žå¼ºæ‰©æ•£æ­¥éª¤ä¸­æ¡ä»¶ä¿¡æ¯çš„å½±å“ã€‚åœ¨è¿žç»­å›¾æ‰©æ•£ç½‘ç»œä¸­ï¼Œä¸ä»…ä½¿ç”¨SEï¼ˆ3ï¼‰-ç­‰å˜å±€éƒ¨åŒæž„çš„æ–°å±‚æ¬¡æ¥è¯„ä¼°å±€éƒ¨ç»“æž„ç›¸ä¼¼æ€§ï¼Œè¿˜ä½¿ç”¨å±€éƒ¨å¸§è½¬æ¢å—æ¥æ•èŽ·å±€éƒ¨å‡ ä½•çš„å…¨å±€å˜åŒ–ã€‚æ­¤å¤–ï¼Œå®ƒè¿˜æ¶‰åŠä¸€ç§å¤šç›®æ ‡ä¼˜åŒ–ç­–ç•¥ï¼Œä»¥åŒæ—¶ä¼˜åŒ–æ‰€ç”Ÿæˆåˆ†å­çš„å¤šç§ç‰¹æ€§ï¼ŒåŒ…æ‹¬ç»“åˆäº²å’ŒåŠ›ã€è¯ç‰©ç›¸ä¼¼æ€§ã€å¯åˆæˆæ€§å’Œæ¯’æ€§ã€‚DiffMC-Genå’ŒåŸºçº¿æ¨¡åž‹ä¹‹é—´çš„æ¯”è¾ƒéªŒè¯äº†DiffMC-Genåœ¨ä¸€èˆ¬ç”Ÿæˆæ€§èƒ½å’Œç”Ÿæˆåˆ†å­çš„é¢„æœŸç‰¹æ€§åˆ†å¸ƒæ–¹é¢å§‹ç»ˆä¼˜äºŽæˆ–åŒ¹é…åŸºçº¿æ¨¡åž‹ã€‚é€šè¿‡ä½¿ç”¨HPK1ã€LRRK2å’ŒGLP-1å—ä½“ä¸‰ä¸ªé¶ç‚¹çš„æ¡ˆä¾‹ç ”ç©¶ï¼ŒèŽ·å¾—çš„ç»“æžœè¡¨æ˜Žï¼ŒåŸºäºŽDiffMC-Genç”Ÿæˆçš„åˆ†å­ä¸ä»…å…·æœ‰è‰¯å¥½çš„ç”Ÿç‰©æ´»æ€§ï¼Œè€Œä¸”ä¿æŒäº†è‰¯å¥½çš„è¯ç‰©æ ·ç‰¹æ€§ã€ç»“æž„å¤šæ ·æ€§å’Œæ–°é¢–æ€§ï¼Œçªå‡ºè¡¨æ˜Žæˆ‘ä»¬çš„æ–¹æ³•å¯ä»¥ç”Ÿæˆå…·æœ‰é¢„æœŸç‰¹æ€§çš„é«˜è´¨é‡å€™é€‰ç‰©ï¼Œå¹¶å°†æˆä¸ºä¸€ç§æœ‰ç”¨çš„ä»Žå¤´å¼€å§‹çš„è¯ç‰©è®¾è®¡å·¥å…·ã€‚

# KinGen

## å¼•è¨€

æ¿€é…¶æ˜¯è®¸å¤šç»†èƒžè¿‡ç¨‹ä¸­çš„å…³é”®è°ƒèŠ‚å› å­ï¼Œå®ƒä»¬çš„å¤±è°ƒä¸ŽåŒ…æ‹¬ç™Œç—‡åœ¨å†…çš„å„ç§ç–¾ç—…æœ‰å…³ã€‚å› æ­¤ï¼Œè›‹ç™½æ¿€é…¶å·²æˆä¸ºç›®å‰ä¸»è¦çš„è¯ç‰©é¶ç‚¹ï¼Œå…¨çƒè¯ç‰©å¼€å‘å·¥ä½œçš„ä¸‰åˆ†ä¹‹ä¸€åˆ°å››åˆ†ä¹‹ä¸€ä¸»è¦é›†ä¸­åœ¨æ¿€é…¶ä¸Šã€‚åŸºäºŽæ·±åº¦å­¦ä¹ çš„åˆ†å­ç”Ÿæˆæ–¹æ³•åœ¨æŽ¢ç´¢å¤§åŒ–å­¦ç©ºé—´å’Œæé«˜è¯ç‰©å‘çŽ°æ•ˆçŽ‡æ–¹é¢æ˜¾ç¤ºå‡ºæ˜Žæ˜¾çš„ä¼˜åŠ¿ã€‚ç„¶è€Œï¼Œè®¸å¤šå½“å‰çš„åˆ†å­ç”Ÿæˆæ¨¡åž‹åœ¨è€ƒè™‘ç‰¹å®šé¶æ ‡å’Œç”Ÿæˆå…·æœ‰æ‰€éœ€ç‰¹æ€§ï¼ˆå¦‚é¶æ ‡ç›¸å…³æ´»æ€§ï¼‰çš„åˆ†å­æ–¹é¢é¢ä¸´æŒ‘æˆ˜ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å¼€å‘äº†ä¸€ä¸ªä¸“é—¨çš„ã€å¢žå¼ºçš„åŸºäºŽæ·±åº¦å­¦ä¹ çš„åˆ†å­ç”Ÿæˆæ¡†æž¶KinGenï¼Œå®ƒæ˜¯ä¸“é—¨ä¸ºé«˜æ•ˆç”Ÿæˆå°åˆ†å­æ¿€é…¶æŠ‘åˆ¶å‰‚è€Œè®¾è®¡çš„ã€‚é€šè¿‡æ•´åˆå¼ºåŒ–å­¦ä¹ ã€è¿ç§»å­¦ä¹ å’Œä¸€ä¸ªä¸“é—¨çš„å¥–åŠ±æ¨¡å—ï¼ŒKinGenå°†äº²å’ŒåŠ›é¢„æµ‹æ¨¡åž‹FusionDTAä½œä¸ºå¥–åŠ±å‡½æ•°ï¼Œä½¿å…¶èƒ½å¤Ÿå‡†ç¡®åœ°å°†ç”Ÿæˆè¿‡ç¨‹å¼•å¯¼åˆ°å…·æœ‰é«˜é¶æ´»æ€§çš„ç”Ÿç‰©ç›¸å…³åˆ†å­ã€‚è¿™ç§æ–¹æ³•ä¸ä»…ç¡®ä¿äº†ç”Ÿæˆçš„åˆ†å­å…·æœ‰ç†æƒ³çš„æŒ‡å‘æ€§ï¼Œè€Œä¸”æé«˜äº†åˆ†å­ä¼˜åŒ–çš„æ•ˆçŽ‡ã€‚ç»“æžœè¡¨æ˜Žï¼ŒKinGenå¯ä»¥ç”Ÿæˆç»“æž„æœ‰æ•ˆã€ç‹¬ç‰¹å’Œå¤šæ ·çš„åˆ†å­ã€‚ç”Ÿæˆçš„åˆ†å­æŠ‘åˆ¶ç»“åˆäº²å’Œæ€§ï¼Œä¸Žç›®å‰çš„æŠ‘åˆ¶å‰‚ç›¸å½“ï¼Œå¹³å‡ç»“åˆèƒ½ä¸º-9.5kcal/molï¼Œè¿™çªæ˜¾äº†è¯¥æ¨¡åž‹è®¾è®¡åŒ–åˆç‰©çš„èƒ½åŠ›ï¼Œè¿™äº›ç»“æžœè¡¨æ˜Žï¼ŒKinGenæœ‰å¯èƒ½ä¸ºåŠ é€Ÿæ¿€é…¶é¶å‘è¯ç‰©çš„å‘çŽ°æä¾›ä¸€ç§æœ‰æ•ˆçš„æ–¹æ³•ã€‚

## æ•°æ®

- `ChEMBL` : 2.3mï¼Œæ¸…æ´—å®Œä¹‹åŽçº¦ 2.1m
- `Davis` : åŒ…å« 30,056 æ¡æ•°æ®ï¼Œæ¶µç›– 442 è›‹ç™½ 68 é…ä½“ã€‚
- `KIBA` : 467 è›‹ç™½ and 52,498 é…ä½“ï¼ˆåŽŸå§‹è®ºæ–‡åŒ…å« 118,254 æ¡æ•°æ®ï¼Œæ¶µç›– 229 è›‹ç™½ 2111 é…ä½“ï¼‰
- `BindingDB` : 19 å…·ä½“é¶ç‚¹çš„æ¿€é…¶

![Figure 1](KinGen_1.png)

## æž¶æž„

### Generator

![Figure 2](KinGen_2.png)

- **RNN-Based Prior Generation Model:** åŸºäºŽGRUçš„å¾ªçŽ¯ç¥žç»ç½‘ç»œï¼Œç”¨äºŽé¢„è®­ç»ƒå¹¶æ•èŽ·SMILESåºåˆ—çš„åŒ–å­¦çŸ¥è¯†ï¼Œä½¿ç”¨ ChEMBL SMILES è®­ç»ƒ
- **Reward Moduleï¼š** ç»“åˆå¼ºåŒ–å­¦ä¹ ï¼ˆReinforcement Learning, RLï¼‰æ¥ä¼˜åŒ–åˆ†å­ç”Ÿæˆè¿‡ç¨‹ï¼ŒReward Module ç”¨äºŽè¯„ä¼°ç”Ÿæˆçš„åˆ†å­å¹¶å¼•å¯¼æ¨¡åž‹ç”Ÿæˆæ›´ä¼˜çš„åŒ–åˆç‰©ã€‚å¥–åŠ±å‡½æ•°ï¼ˆReward Functionï¼‰ç”± ç»“åˆäº²å’ŒåŠ›é¢„æµ‹æ¨¡åž‹ï¼ˆFusionDTAï¼‰ å’Œ å¤šæ ·æ€§è¿‡æ»¤å™¨ï¼ˆDiversity Filterï¼‰ç»„æˆï¼Œä¸¤è€…ç»“åˆç¡®å®šä¸€ä¸ªæ‰“åˆ†ï¼ŒæŸå¤±å‡½æ•°å®šä¹‰å¦‚ä¸‹ï¼š

    $$
    \text{Loss} = \left[\log P(A)_{\text{augmented}} - \log P(A)_{\text{agent}}\right]^2
    $$

    å…¶ä¸­ï¼š

    $$
    \log P(A)_{\text{augmented}} = \log P(A)_{\text{prior}} + \sigma \cdot \text{Score}(A)
    $$

    - $$ \log P(A)_{\text{prior}} $$ï¼šPrior Model ç»™å‡ºçš„åˆ†å­ç”Ÿæˆæ¦‚çŽ‡  
    - $$ \text{Score}(A) $$ï¼šç”± Reward Module è®¡ç®—çš„æ€»å¾—åˆ†  
    - $$ \sigma $$ï¼šç¼©æ”¾å› å­ï¼Œå¹³è¡¡ Prior Model ä¸Ž Reward çš„å½±å“
- **Transfer Learning and update module:** ç”¨äºŽå°†é¢„è®­ç»ƒçš„é€šç”¨è¯ç‰©-é¶æ ‡äº²å’ŒåŠ›é¢„æµ‹æ¨¡åž‹ï¼ˆFusionDTAï¼‰é€‚é…åˆ°ç‰¹å®šæ¿€é…¶é¶æ ‡ï¼ŒDavis æµ‹è¯•é›† CI = 0.911ï¼ŒKIBA æµ‹è¯•é›† CI = 0.850ï¼Œä½†å¯¹å•ä¸ªæ¿€é…¶ï¼ˆå¦‚ ALKï¼‰ çš„é¢„æµ‹æ€§èƒ½è¾ƒå·®ï¼ˆCI â‰ˆ 0.5ï¼ŒæŽ¥è¿‘éšæœºçŒœæµ‹ï¼‰ã€‚é€šè¿‡æ•´åˆæ¿€é…¶æ•°æ®é›†å¾—åˆ°æ¿€é…¶ç‰¹å®šæ•°æ®é›†ï¼ˆSpecificï¼‰å’Œæ··åˆæ•°æ®é›†ï¼ˆAllï¼‰ï¼Œä¾‹å¦‚ ALK æŠ‘åˆ¶å‰‚æ•°æ®ï¼ˆ1,943 ä¸ªæ ·æœ¬ï¼‰ï¼ŒæŒ‰ 5:1 åˆ’åˆ†ä¸ºè®­ç»ƒé›†å’Œæµ‹è¯•é›†ï¼Œå…¶ä»– 16 ä¸ªæ¿€é…¶ç±»ä¼¼å¤„ç†ï¼ˆå¦‚ EGFRã€JAK1 ç­‰ï¼‰ï¼Œæ··åˆæ•°æ®é›†åˆå¹¶æ‰€æœ‰ 17 ä¸ªæ¿€é…¶çš„è®­ç»ƒæ•°æ®ï¼ˆå…± 72,920 ä¸ªæ ·æœ¬ï¼‰ï¼Œç”¨äºŽè®­ç»ƒé€šç”¨é€‚é…æ¨¡åž‹ã€‚åŠ è½½é¢„è®­ç»ƒçš„ FusionDTA æƒé‡å†»ç»“åº•å±‚ä¿ç•™ ESM-1b è›‹ç™½è´¨ç¼–ç å™¨å’Œ BiLSTM çš„æƒé‡ï¼ˆé€šç”¨ç‰¹å¾æå–èƒ½åŠ›ï¼‰ã€‚å¾®è°ƒé¡¶å±‚ä»…æ›´æ–°æ³¨æ„åŠ›å±‚å’Œå…¨è¿žæŽ¥å±‚çš„å‚æ•°ï¼Œé€‚é…ç‰¹å®šæ¿€é…¶æ•°æ®ã€‚

### Evaluator

ä½¿ç”¨åˆ†å­å¯¹æŽ¥å’Œè¯æ•ˆå›¢åŒ¹é…è¿›è¡ŒéªŒè¯

![Figure 3](KinGen_3.png)

## è¯„ä»·æŒ‡æ ‡

- `Glide score` : ä¼°è®¡é…ä½“å’Œé¶æ ‡ä¹‹é—´çš„ç»“åˆäº²å’ŒåŠ›
- `Success rate` : åŒæ—¶æ»¡è¶³ç»“åˆäº²å’ŒåŠ›ï¼ˆpIC50 > 5ï¼‰å’Œç»“æž„æ–°é¢–æ€§ï¼ˆTanimotoç›¸ä¼¼æ€§<0.7ï¼‰çš„åˆ†å­æ¯”ä¾‹
- `Novelty` : ä»£è¡¨äº†æ¨¡åž‹ç”Ÿæˆä¸Žè®­ç»ƒé›†ä¸­çš„åˆ†å­æˆ–çŽ°æœ‰å·²çŸ¥åˆ†å­ç»“æž„ä¸åŒçš„åˆ†å­çš„èƒ½åŠ›
- `Uniqueness` : ç”Ÿæˆçš„åˆ†å­çš„åŒ–å­¦å›¾åœ¨ç”Ÿæˆçš„æ ·å“ä¸­æ˜¯å¦å”¯ä¸€
- `Validity` : éµå®ˆå¸¸è§åŒ–å­¦è§„åˆ™ï¼ˆå¦‚åŒ–åˆä»·ï¼‰çš„ç”Ÿæˆåˆ†å­
- `Diversity` : åŸºäºŽBemis-Murckoéª¨æž¶çš„å¤šæ ·æ€§
- `Recovery` : ä¿ç•™å·²çŸ¥é…ä½“å…³é”®ç‰‡æ®µçš„æ¯”ä¾‹

## ç»“æžœ

![Figure 4](KinGen_4.png)


![Figure 5](KinGen_5.png)


![Figure 6](KinGen_6.png)


![Figure 7](KinGen_7.png)


![Figure 8](KinGen_8.png)


![Figure 9](KinGen_9.png)

# å‚è€ƒæ–‡çŒ®

[DiffMC-Gen: A Dual Denoising Diffusion Model for Multi-Conditional Molecular Generation, 2025-04](https://doi.org/10.1002/advs.202417726)

[A Specialized and Enhanced Deep Generation Model for Active Molecular Design Targeting Kinases Guided by Affinity Prediction Models and Reinforcement Learning, 2025-04](https://doi.org/10.1021/acs.jcim.5c00074)
